TO MANDATE COVERAGE FOR CERTAIN RESPIRATORY SYNCYTIAL VIRUS DISEASE IMMUNIZATION TECHNOLOGIES FOR CERTAIN INDIVIDUALS.

HB 1052 would require health insurance plans in Arkansas to cover respiratory syncytial virus (RSV) immunization for infants under eight months old, using a specific antibody treatment, without cost-sharing like deductibles or copayments. This mandate applies to all health benefit plans, including Medicaid and the Arkansas Health and Opportunity for Me Program, starting January 1, 2026. The bill also directs state agencies to create implementing rules by that date to ensure compliance.